Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27Kip1 and p21Cip1

Cancer Cell

Volumn 7, Issue 6, 2005, Pages 591-598

  Martín, Alberto ^a   Odajima, Junko ^a   Hunt, Sarah L ^a   Dubus, Pierre ^b   Ortega, Sagrario ^a   Malumbres, Marcos ^a   Barbacid, Mariano ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; FIBROBLAST; HYPOPHYSIS TUMOR; MITOSIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

EID: 20444410393     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2005.05.006     Document Type: Article

References (38)

1. C. Berthet, E. Aleem, V. Coppola, L. Tessarollo, and P. Kaldis Cdk2 knockout mice are viable Curr. Biol. 13 2003 1775 1785
2. Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4 J. Biol. Chem. 272 1997 25863 25872
3. S.W. Blain, H.I. Scher, C. Cordon-Cardo, and A. Koff p27 as a target for cancer therapeutics Cancer Cell 3 2003 111 115
4. J. Bloom, and M. Pagano Deregulated degradation of the cdk inhibitor p27 and malignant transformation Semin. Cancer Biol. 13 2003 41 47
5. J. Brugarolas, C. Chandrasekaran, J.I. Gordon, D. Beach, T. Jacks, and G.J. Hannon Radiation-induced cell cycle arrest compromised by p21 deficiency Nature 377 1995 552 557
6. C. Cayrol, M. Knibiehler, and B. Ducommun p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells Oncogene 16 1998 311 320
7. J. Chen, P.K. Jackson, M.W. Kirschner, and A. Dutta Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA Nature 374 1995 386 388
8. Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts EMBO J. 18 1999 1571 1583
9. Kip1 J. Biol. Chem. 275 2000 21960 21968
10. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control Cell 82 1995 675 684
11. C. Denicourt, and S.F. Dowdy Cip/Kip proteins: More than just CDKs inhibitors Genes Dev. 18 2004 851 855
12. Kip1)-deficient mice Cell 85 1996 733 744
13. M.L. Fero, E. Randel, K.E. Gurley, J.M. Roberts, and C.J. Kemp The murine gene p27Kip1 is haplo-insufficient for tumour suppression Nature 396 1998 177 180
14. J.W. Harper, S.J. Elledge, K. Keyomarsi, B. Dynlacht, L.H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley, and E. Swindell Inhibition of cyclin-dependent kinases by p21 Mol. Biol. Cell 6 1995 387 400
15. H. Kiyokawa, R.D. Kineman, K.O. Manova-Todorova, V.C. Soares, E.S. Hoffman, M. Ono, D. Khanam, A.C. Hayday, L.A. Frohman, and A. Koff Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1) Cell 85 1996 721 732
16. K. Kozar, M.A. Ciemerych, V.I. Rebel, H. Shigematsu, A. Zagozdzon, E. Sicinska, Y. Geng, Q. Yu, S. Bhattacharya, and R.T. Bronson Mouse development and cell proliferation in the absence of d-cyclins Cell 118 2004 477 491
17. T.K. Kwon, and A.A. Nordin Identification of cdk2 binding sites on the p27Kip1 cyclin-dependent kinase inhibitor Oncogene 16 1998 755 762
18. J. LaBaer, M.D. Garrett, L.F. Stevenson, J.M. Slingerland, C. Sandhu, H.S. Chou, A. Fattaey, and E. Harlow New functional activities for the p21 family of CDK inhibitors Genes Dev. 11 1997 847 862
19. R. Li, S. Waga, G.J. Hannon, D. Beach, and B. Stillman Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair Nature 371 1994 534 537
20. J. Lin, C. Reichner, X. Wu, and A.J. Levine Analysis of wild-type and mutant p21WAF-1 gene activities Mol. Cell. Biol. 16 1996 1786 1793
21. S.W. Lowe, E. Cepero, and G. Evan Intrinsic tumour suppression Nature 432 2004 307 315
22. Cip1 Nature 375 1995 159 161
23. M. Malumbres, and A. Carnero Cell cycle deregulation: A common motif in cancer Prog. Cell Cycle Res. 5 2003 5 18
24. M. Malumbres, R. Sotillo, D. Santamaria, J. Galan, A. Cerezo, S. Ortega, P. Dubus, and M. Barbacid Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6 Cell 118 2004 493 504
25. J. Martín-Caballero, J.M. Flores, P. Garcia-Palencia, and M. Serrano Tumor susceptibility of p21(Waf1/Cip1)-deficient mice Cancer Res. 61 2001 6234 6238
26. K. Nakayama, and K. Nakayama Cip/Kip cyclin-dependent kinase inhibitors: Brakes of the cell cycle engine during development Bioessays 20 1998 1020 1029
27. Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors Cell 85 1996 707 720
28. K. Nakayama, H. Nagahama, Y.A. Minamishima, S. Miyake, N. Ishida, S. Hatakeyama, M. Kitagawa, S. Iemura, T. Natsume, and K.I. Nakayama Skp2-mediated degradation of p27 regulates progression into mitosis Dev. Cell 6 2004 661 672
29. S. Ortega, I. Prieto, J. Odajima, A. Martín, P. Dubus, R. Sotillo, J.L. Barbero, M. Malumbres, and M. Barbacid Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice Nat. Genet. 35 2003 25 31
30. M. Pagano Control of DNA synthesis and mitosis by the Skp2-p27-Cdk1/2 axis Mol. Cell 14 2004 414 416
31. S.I. Reed Ratchets and clocks: The cell cycle, ubiquitylation and protein turnover Nat. Rev. Mol. Cell Biol. 4 2003 855 864
32. S. Ren, and B.J. Rollins Cyclin C/Cdk3 promotes Rb-dependent G0 exit Cell 117 2004 239 251
33. C.J. Sherr, and J.M. Roberts Cdk inhibitors: Positive and negative regulators of G1-phase progression Genes Dev. 13 1999 1501 1512
34. S. Sotillo, P. Dubus, J. Martin, E. de la Cueva, S. Ortega, M. Malumbres, and M. Barbacid Wide spectrum of tumors in knock in mice carrying a Cdk4 protein insensitive to INK4 inhibitors EMBO J. 20 2001 6637 6647
35. H. Toyoshima, and T. Hunter p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21 Cell 78 1994 67 74
36. K.H. Vousden, and C. Prives P53 and prognosis: New insights and further complexity Cell 120 2005 7 10
37. S. Waga, G.J. Hannon, D. Beach, and B. Stillman The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA Nature 369 1994 574 578
38. X. Ye, C. Zhu, and J.W. Harper A premature-termination mutation in the Mus musculus cyclin-dependent kinase 3 gene Proc. Natl. Acad. Sci. USA 98 2001 1682 1686